The origin and evolution of human T-cell lymphotropic virus type II (HTLV-II) and the relationship with its replication strategy

Gene

Volumn 234, Issue 1, 1999, Pages 11-21

  Salemi, Marco ^a   Vandamme, Anne Mieke ^a   Desmyter, Jan ^a   Casoli, Claudio ^b   Bertazzoni, Umberto ^c  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b UNIVERSITY OF PARMA   (Italy)

^c UNIVERSITY OF VERONA   (Italy)

Author keywords

Amerindians; Clonal expansion; Evolution; Genomic stability; HTLV II; Injecting drug users (IDUs); Origin

Indexed keywords

DRUG ABUSE; GENETIC STABILITY; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 2; PHYLOGENY; PRIORITY JOURNAL; REVIEW; VIRUS REPLICATION; VIRUS TRANSMISSION;

EVOLUTION; GENOME, VIRAL; HTLV-II INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 2; HUMANS; SUBSTANCE ABUSE, INTRAVENOUS; VARIATION (GENETICS); VIRUS REPLICATION;

EID: 0032967203     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1119(99)00169-9     Document Type: Review

References (92)

1. Biggar R.J., Taylor M.E., Neel J.V., Hjelle B., Levine P.H., Black F.L., Shaw G.M., Sharp P.M., Hahn B.H. Genetic variants of human T-lymphotropic virus type II in American Indian groups. Virology. 216:1996;165-173.
2. Biglione M., Gessain A., Quiruelas S., Fay O., Taborda M.A., Fernandez E., Lupo S., Panzita A., de Thé G. Endemic HTLV-II infection among Tobas and Matacos Amerindians from north Argentina [letter]. J. Acquir. Immune Defic. Syndrome. 6:1993;631-633.
3. Black F.L. Tracing prehistoric migrations by the viruses they carry: human T-cell lymphotropic viruses as markers of ethnic relationships. Hum. Biol. 69:1997;467-482.
4. Black F.L., Biggar R.J., Neel J.V., Maloney E.M., Waters D.J. Endemic transmission of HTLV type II among Kayapo Indians of Brazil. AIDS Res. Hum. Retrovir. 10:1994;1165-1171.
5. Casoli C., Cimarelli A., Bertazzoni U. Cellular tropism of human T-cell leukemia virus type II is enlarged to B lymphocytes in patients with high proviral load. Virology. 206:1995;1126-1128.
6. Casoli C., Re M.C., Monari P., Furlini G., Tosi G., Gradozzi C., Dall'Aglio P.P., Bertazzoni U., Accolla R.S. Human T-cell leukemia virus type II directly acts on CD34+ hematopoietic precursors by increasing their survival potential. Envelope-associated HLA class II molecules reverse this effect. Blood. 91:1998;2296-2304.
7. Cavalli-Sforza L.L., Menozzi P., Piazza A. The History and Geography of Human Genes. 1994;Princeton University Press, Princeton, NJ.
8. Chen J., Zekeng L., Yamashita M., Takeisha J., Miura T., Ido E., Mboudjeka I., Tsague J.M., Hayami M., Kaptue L. HTLV isolated from a Pygmy in Cameroon is related but distinct from the known Central African type. AIDS Res. Hum. Retrovir. 11:1995;1529-1531.
9. Chou K.S., Okayama A., Su I.J., Lee T.-H., Essex M. Preferred nucleotide sequence at the integration target site of human T-cell leukemia virus type I from patients with adult T-cell leukemia. Int. J. Cancer. 65:1996;20-24.
10. Cimarelli A., Duclos C.A., Gessain A., Casoli C., Bertazzoni U. Clonal expansion of human T-cell leukemia virus type II in patients with high proviral load. Virology. 223:1996;362-364.
11. Cimarelli A., Duclos C.A., Gessain A., Cattaneo E., Casoli C., Biglione M., Mauclère P., Bertazzoni U. Quantification of HTLV-II proviral copies by competitive polymerase chain reaction in peripheral blood mononuclear cells of Italian injecting drug users, Central Africans and Amerindians. J. Acquir. Immune Defic. Syndrome. 10:1995;198-204.
12. Coates S.R., Harris A.J., Parkes D.L., Smith C.M., Liu H.L.C., Akita R.W., Ferrer M.M., Sampson E.K., Brandis J.W., Sliwkowski M.X. Serological evaluation of Escherichia coli-expressed human T-cell leukemia virus type I env, gag p24 and tax proteins. J. Clin. Microbiol. 28:1990;1139.
13. Delaporte E., Monplaisir N., Louwagie J., Peeters M., Martin-Prével Y., Louis J.-P., Trebucq A., Bedjabaga L., Ossari S., Honoré C., Larouzé B., d'Auriol L., van der Groen G., Piot P. Prevalence of HTLV-I and HTLV-II infection in Gabon, Africa: comparison of the serological and PCR results. Int. J. Cancer. 49:1991;373-376.
14. Duenas-Barajas E., Bernal J.E., Vaught D.R., Briceno I., Duran C., Yanagihara R.I., Gajdusek D.C. Coexistence of human T-cell lumphotropic virus type I and II among the Wayu Indians from the Guajira region of Colombia. AIDS Res. Hum. Retrovir. 8:1993;1851-1855.
15. Duenas-Barajas E., Bernal J.E., Vaught D.R., Nerurkar V.R., Sarmiento P., Yanagihara R.I., Gajdusek D.C. Human retroviruses in Amerindians of Columbia: high prevalence of human T-cell lymphotropic virus type II infection among the Tunebo Indians. Am. J. Trop. Med. Hygiene. 49:(6):1993;657-663.
16. Ehrlich G.D., Glaser S.B., Vigne K.L., Quan D., Mildvan D., Sninsky J.J., Kwo S., Pâsoderp L., Poiesz B.J. Prevalence of human leukemia/lymphoma virus (HTLV) type II infection among high risk individuals, type-specific identification of HTLVs by polymerase chain reaction. Blood. 74:1989;1658-1664.
17. Eiraku N., Monken C., Kubo T., Zhu S.W., Rios M., Bianco C., Hjelle B., Nagashima K., Hall W.W. Nucleotide sequence and restriction fragment length polymorphism analysis of the long terminal repeat of human T cell leukemia virus type II. AIDS Res. Hum. Retrovir. 11:1995;625-636.
18. Eiraku N., Novoa P., da Costa Ferreira M., Monken C., Ishak R., da Costa Ferreira O., Zhu S.W., Lorenco R., Ishak M., Azvedo V., Guerreiro J., Pombo de Oliveira M., Loureiro P., Hammerschlak N., Ijichi S., Hall W.W. Identification and characterization of a new and distinct molecular subtype of human T-cell lymphotropic virus type 2. J. Virol. 70:1996;1481-1492.
19. Felsenstein J. PHYLIP: Phylogenetic Inference Package, version 3.5c. 1993;Seattle: Department of Genetics, University of Washington.
20. Ferrer J.F., Pino N.D., Esteban E., Sherman M.P., Dube S., Dube D.K., Basombrio M.A., Pimentel E., Segovia A., Quirulas S., Poiesz J. High rate of infection with the human T-cell leukemia retrovirus type II in four Indian populations of Argentina. J. Virol. 197:1993;576-584.
21. Froment A., Delaporte E., Dazza M.-C., Larouze B. HTLV-II among Pygmies from Cameroon [letter]. AIDS Res. Hum. Retrovir. 9:1993;707.
22. Fukushima Y., Takahashi H., Hall W.W., Nakasone T., Nakata S., Song P., Duc D.D., Hien B., Quang N.X., Trinh T.N., Nishioka K., Kitamura K., Komuro K., Vahlne A., Honda M. Extraordinary high rate of HTLV type II seropositivity in intravenous drug abusers in South Vietnam. AIDS Res. Hum. Retrovir. 11:1995;637-644.
23. Gessain A., Barin F., Vernant J.C., Gout O., Maurs L., Calender A., de Thé G. Antibodies to human T lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet. 2:1985;407-410.
24. Gessain A., Gallo R.C., Franchini G. Low degree of human T-cell leukemia/lymphoma virus type I genetic drift in vivo as a means of monitoring viral transmission and movement of ancient human populations. J. Virol. 66:1992;2288-2295.
25. Gessain A., Mauclère P., Froment A., Biglione M., Hesran J.Y.L., Tekaia F., Millan J., de Thé G. Isolation and molecular characterization of human T-cell lymphotropic virus type II (HTLV-II), subtype B, from a healthy pygmy living in a remote area of Cameroon: an ancient origin for HTLV-II in Africa. Proc. Natl. Acad. Sci. USA. 92:1995;4041-4045.
26. Gessain A., Yanahigara R., Franchini G., Garruto R.M., Jenkins C.L., Ajdukiewicz A.B., Gallo R.C., Gajdusek D.C. Highly divergent molecular variants of human T-lymphotropic virus type I from isolated populations in Papua New Guinea and the Solomon Islands. Proc. Natl. Acad. Sci USA. 88:1991;7684-7698.
27. Giri A., Markham P., Digilio L., Hurteau G., Gallo R.C., Franchini G. Isolation of a novel simian T-cell lymphotropic virus from Pan paniscus that is distantly related to the human T-cell leukemia/lymphotropic virus types I and II. J. Virol. 68:1994;8392-8395.
28. Goubau P., Desmyter J., Ghesquiere J., Kasereka B. HTLV-II among pygmies [letter]. Nature. 359:1992;201.
29. Goubau P., Liu H.-F., De Lange G.G., Vandamme A.-M., Desmyter J. HTLV-II seroprevalence in pygmies across Africa since 1970. AIDS Res. Hum. Retrovir. 9:1993;709-713.
30. Goubau P., Vandamme A.-M., Beuselinck K., Desmyter J. Proviral HTLV-I and HTLV-II in the Efe pygmies of northeastern Zaire. J. Acquir. Immune Defic. Syndrome. 12:1993;208-210.
31. Goubau P., Vandamme A.-M., Beuselinck K., Desmyter J. Proviral HTLV-I and HTLV-II in the Efe Pygmies of Northeastern Zaire. J. Acquir. Immune Defic. Syndrome. 12:1996;208-210.
32. Green P.L., Xie Y.M., Chen I.S. The internal methionine codons of human T-cell leukemia virus type II rex gene are not required for p24rex production or virus replication and transformation. J. Virol. 64:1990;4914-4921.
33. Hall W.W., Ishak R., Zhu S.W., Novoa P., Eiraku N., Takahashi H., Ferreira da M C., Azevedo V., Ishak M.O., Ferreira da O C., Monken C., Kurata T. Human T lymphotropic virus type II (HTLV-II): epidemiology, molecular properties and clinical features of infection. J. Acquir. Immune Defic. Syndrome. 13:1996;S204-S214.
34. Hall W.W., Takahashi H., Liu C., Kaplan M.H., Scheewind O., Ijichi S., Nagashima K., Gallo R.C. Multiple isolates and characteristics of human T-cell leukemia virus type II. J. Virol. 66:1992;2456-2463.
35. Hall W.W., Takayuki K., Ijichi S., Takahashi H., Zhu S.W. Human T cell leukemia/lymphoma virus type II (HTLV-II): emergence of an important newly recognized pathogen. Sem. Virol. 5:1994;165-178.
36. Heneine W. the phylogeny and molecular epidemiology of human T-cell lymphotropic virus type II. J. Acquir. Immune Defic. Syndrome. 13:1996;S236-S241.
37. Hjelle B., Appenzeller O., Mills R., Alexander S., Torrez-Martinez N., Jahnke R., Ross G. Chronic neurodegenerative disease associated with HTLV-II infection. Lancet. 339:1992;645-646.
38. Hjelle B., Zhu S.W., Takahashi H., Ijichi S., Hall W.W. Endemic human T cell leukemia virus type II infection in southwestern US Indians involves two prototype variants of virus. J. Infect. Dis. 168:1993;737-740.
39. Ho G.Y., Nomura A.M., Nelson K., Lee H., Polk B.F., Blattner W.A. Declining seroprevalence and transmission of HTLV-I in Japanese families who immigrated to Hawaii. see comments Am. J. Epidemiol. 134:(9):1991;981-987.
40. Ibrahim F., de Thé G., Gessain A. Isolation and characterization of a new simian T-cell leukemia virus type I from naturally infected Celebes macaques (Macaca tonkeana): complete nucleotide sequence and phylogenetic relationship with the Australo-Melanesian human T-cell leukemia virus type I. J. Virol. 69:1995;6980-6993.
41. Ijichi S., Ramundo M.B., Takahashi H., Hall W.W. In vivo cellular tropism of human T cell leukemia virus type II (HTLV-II). J. Exp. Med. 176:1992;293-296.
42. Ijichi S., Zaninovic V., Leon F.E., Katahira Y., Sonoda S., Miura T., Hayami M., Hall W.W. Identification of human T-cell leukemia virus type IIb infection in the Wayu, an aboriginal population of Colombia. Jpn J. Cancer Res. 84:1993;1215-1218.
43. Jacobson K.T., Shida H., McFarlin D.E., Fauci A.S., Koenig S. Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature. 348:1990;245.
44. Kalyanaraman V.S., Sarngadharan M.G., Robert-Guroff M., Miyoshi I., Golde D., Gallo R.C. A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Science. 218:1982;571-573.
45. Kashiwagi S., Kajiyama W., Hayashi J., Noguchi A., Nakashima K., Nomura H., Ikematsu H., Sawada T., Kida S., Koide A. Antibody to p40tax protein of human T cell leukemia virus I and infectivity. J. Infect. Dis. 161:1990;426.
46. Koyanagi Y., Itoyama Y., Nakamura N., Takamatsu K., Kira J.I., Iwamasa T., Goto I., Yamamoto N. In vivo infection of human T-cell leukemia virus type I in non-T cells. Virology. 196:1993;25-33.
47. Krook A., Albert J., Andersson S., Biberfeld G., Blomberg J., Eklund I., Engstrom A., Julander I., Kall A., Martin C., Stendahl P., Struve J., Sonnerborg A. Prevalence and risk factors for HTLV-II infections in 913 injecting drug users in Stockholm, 1994. J. Acquir. Immune Defic. Syndrome. 15:1997;381-386.
48. Lairmore M.D., Jacobson S., Gracia F., De B.K., Castillo L., Larreategui M., Roberts B.D., Levine P.H., Blattner W.A., Kaplan J.E. Isolation of human T-cell lymphotropic virus type II from Guaymi Indians in Panama. Proc. Natl. Acad. Sci. USA. 87:1990;8840-8844.
49. Lee H., Idler K., Swanson P., Aparicio J.J., Chin K.K., Lax J.P., Nguyen M., Mann T., Leckie G., Zanetti A., Marinucci G., Chen I., Rosenblatt J.D. Complete nucleotide sequence of HTLV-II isolate NRA. Comparison of envelope sequence variation of HTLV-II isolates from U.S. Blood donors and A.S. and Italian IV drug users. Virology. 196:1993;57-69.
50. Lee H., Swanson P., Shorty V.S., Zack J.A., Rosenblatt J.D., Chen I.S.Y. High rate of HTLV-II infection in seropositive IV drug abusers in New Orleans. Science. 244:1989;471-475.
51. Levine P.H., Jacobson S., Elliott R., Cavallero A., Colclough G., Dorry C., Stephenson C., Knigge R.M., Drummond J., Nishimura M., Taylor M.E., Wiktor S., Shaw G.M. HTLV-II infection in Florida Indians. AIDS Res. Hum. Retrovir. 9:1993;123-127.
52. Lin M.T., Nguyen B.T., Binh T.V., Be T.V., Chiang T.Y., Tseng L.H., Yang Y.C., Lin K.H., Chen Y.C. Human T-lymphotropic virus type II infection in Vietnamese thalassemic patients. Arch. Virol. 142:1997;1429-1440.
53. Lindholm P.F., Marriot S.J., Gitlin S.D., Bohan C.A., Brady J.N. Induction of nuclear NF-kB DNA binding activity after exposure of lymphoid cells to soluble Tax1 protein. New Biol. 2:1990;1034.
54. Liu H.F., Vandamme A.-M., Van Brussel M., Desmyter J., Goubau P. New retroviruses in human and simian T-lymphotropic viruses. Lancet. 344:(8917):1994;265-266.
55. Liu H.F., Goubau P., Van Brussel M., Van Laethem K., Chen Y.C., Desmyter J., Vandamme A.-M. The three human T-lymphotropic virus type I subtypes arose from three geographically distinct simian reservoirs. J. Gen. Virol. 77:1996;359-368.
56. Mahieux R., Ibrahim F., Mauclere P., Herve V., Michel P., Tekaia F., Chappey C., Garin B., Van Der Ryst E., Guillemain B., Ledru E., Delaporte E., De The G.G., Gessain A. Molecular epidemiology of 58 new African human T-cell leukemia virus type I (HTLV-I) strains: identification of a new distinct HTLV-I molecular subtype in Central Africa and in Pygmies. J. Virol. 71:1997;1317-1333.
57. Maloney E.M., Biggar R.J., Neel J.V., Taylor M., Hahn B.H., Shaw G.M., Blattner W.A. Endemic human T cell lymphotropic virus type II infection among isolated Brazilian Amerindians. J. Infect. Dis. 166:1992;100-107.
58. Mansky L.M., Temin H.M. Lower mutation rate of bovine leukemia virus relative to that of spleen necrosis virus. J. Virol. 68:1994;494-499.
59. Mansky L.M., Temin H.M. Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from thefidelity of purified reverse transcriptase. J. Virol. 69:1995;5087-5094.
60. Miura T., Fukunaga T., Igarashi T., Yamashita M., Ido E., Funahashi S.I., Ishida T., Washio K., Ueda S., Hashimoto K.I., Yoshida M., Osame M., Singhal B.S., Zaninovic V., Cartier L., Sonoda S., Tajima K., Ina Y., Gojobori T., Hayami M. Phylogenetic subtypes of human T-lymphotropic virus type I and their relations to the anthropological background. Proc. Natl. Acad. Sci. USA. 91:1994;1124-1127.
61. Modahl L.E., Young K.C., Varney K.F., Khayam-Bashi H., Murphy E.L. Are HTLV-II-seropositive injection drug users at increased risk of bacterial pneumonia, abscess and lymphadenopathy? J. Acquir. Immune Defic. Syndrome. 16:1997;169-175.
62. Müller N., Okayama A., Stuver S., Tachibana N. Findings from the Miyazaki Cohort Study. J. Acquir. Immune Defic. Syndrome. 13:1996;S2-S7.
63. Murphy E.L., Friday J., Smith J.W., Engstrom J., Sacher R.A., Miller K., Gibble J., Stevens J., Thomson R., Hansma D., Kaplan J., Khabbaz R., Nemo G. HTLV-associated myelopathy in a cohort of HTLV-I and HTLV-II-infected blood donors - the REDS investigators. Neurology. 48:1997;315-320.
64. Musto D.F. Early history of heroin in The United States. Bourne P.G. Addiction. 1974;Academic Press, New York.
65. Osame M., Matsumoto M., Usuku K., Izumo S., Ijichi N., Amitani H., Tara M., Igata A. Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemia like cells. Ann. Neurol. 21:1987;117-122.
66. Pedroza Martins L., Chenciner N., Wain-Hobson S. Complex intrapatient sequence variation in the V1 and V2 hypervariable regions of the HIV-1 gp120 envelope sequence. Virology. 191:1992;837-845.
67. Poiesz B.J., Ruscetti F.W., Gazdar A.F., Bunn P.A., Minna J.A., Gallo R.C. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. USA. 77:1980;7415-7419.
68. Richardson J.H., Edwards A.J., Cruickshank J.K., Rudge P., Dalgleish A.G. In vivo cellular tropism of human T-cell leukemia virus type 1. J. Virol. 64:1990;5682-5687.
69. Salemi M., Cattaneo E., Casoli C., Bertazzoni U. Identification of IIa and IIb molecular subtypes of human T-cell lymphotropic virus type II among Italian injection drug users. J. Acquir. Immune Defic. Syndrome. 8:1995;516-520.
70. Salemi M., Vandamme A.-M., Guano F., Gradozzi C., Cattaneo E., Casoli C., Bertazzoni U. Complete nucleotide sequence of the Italian human T-cell lymphotropic virus type II isolate Gu and phylogenetic identification of a possible origin of South European epidemics. J. Gen. Virol. 77:1996;1193-1201.
71. Salemi M., Vandamme A.-M., Gradozzi C., Van Laethem K., Cattaneo E., Taylor G., Casoli C., Goubau P., Desmyter J., Bertazzoni U. Evolutionary rate and genetic heterogeneity of human T-cell lymphotropic virus type II (HTLV-II) using new isolates from European injecting drug users. J. Mol. Evol. 46:1998;602-611.
72. Salemi M., Van Dooren S., Audenaert E., Delaporte E., Goubau P., Desmyter J., Vandamme A.-M. Two new human T-lymphotropic virus type I phylogenetic subtypes in seroindeterminates, a Mbuti pygmy and a Gabonese, have closes relatives among African SLTV-I strains. Virology. 243:1998;366-379.
73. Salemi M., Lewis M., Egan J.F., Hall W., Desmyter J., Vandamme A.-M. Different population dynamics and evolutionary rates of human T-cell lymphotropic virus type II (HTLV-II) in injecting drug users compared to in endemically infected Amerindian and pygmy tribes. Proc. Natl. Acad. Sci. USA. 1999;. submitted.
74. Song K.J., Nerurkar V.R., Saitou N., Lazo A., Blakeslee J.R., Miyoshi I., Yanagihara R. Genetic analysis and molecular phylogeny of simian T-cell lymphotropic virus type I: evidence for independent virus evolution in Asia and Africa. Virology. 199:1994;56-66.
75. Suzuki Y., Gojobori T. The origin and evolution of human T-cell lymphotropic virus type I and II. Virus Genes. 16:1998;69-84.
76. Switzer W.M., Black F.L., Pieniazek D., Biggar R.J., Lal R.B., Heneine W. Endemicity and phylogeny of the human T cell lymphotropic virus type II subtype A from the Kayapo indians of Brazil: evidence for limited regional dissemination. AIDS Res. Hum. Retrovir. 12:1996;635-640.
77. Takahashi H., Zhu S.H., Ijichi S., Vahlne A., Suzuki H., Hall W.W. Nucleotide sequence analysis of human T-cell leukemia virus, type II (HTLV-II) isolates. AIDS Res. Hum. Retrovir. 9:1993;721-732.
78. Seroepidemiology of the human T-cell leukaemia/lymphoma viruses in Europe. J. Acquir. Immune Defic. Syndrome Hum. Retrovirol. 13:(1):1996;68-77.
79. Tuppin P., Gessain A., Kazanji M., Mahieux R., Cosnefroy J.-F., Tekaia F., Georges-Courbot M.-C., Georges A., de Thé G. Evidence in Gabon for an intrafamilial clustering with mother-to-child and sexual transmission of new molecular variant of human T-lymphotropic virus type-II subtype b. J. Med. Virol. 48:1996;22-32.
80. Vallejo A., Garcia-Saiz A. Isolation and nucleotide sequence analysis of human T-cell lymphotropic virus type II in Spain. J. Acquir. Immune Defic. Syndrome. 7:1994;517-519.
81. Vallejo A., Ferrante P., Soriano V., Calabro M.L., Mancuso R., Heredia A., Mannella E., Favero A., Garcia-Saiz A., Chieco-Bianchi L., Gonzalez-Lahoz J., Hewlett I.K. Nucleotide sequence and restriction fragment-length polymorphism analysis of human T-cell lymphotropic virus type II (HTLV-II) in southern Europe: evidence for the HTLV-IIa and HTLV-IIb subtypes. J. Acquir. Immune Defic. Syndrome Hum. Retrovirol. 13:(4):1996;384-391.
82. Van Brussel M., Salemi M., Liu H.-F., Goubau P., Desmyter J., Vandamme A.-M. The discovery of two new divergent STLVs has implications for the evolution and epidemiology of HTLVs. Rev. Med. Virol. 1999;. in press.
83. Vandamme A.-M., Liu H.-F., Goubau P., Desmyter J. Primate T-lymphotropic virus type I LTR sequence variation and its phylogenetic analysis: compatibility with an African origin of PTLV-I. Virology. 202:1994;212-223.
84. Vandamme A.-M., Liu H.-F., Van Brussel M., De Meurichy W., Desmyter J., Goubau P. The presence of a divergent T-lymphotropic virus in a wild-caught pygmy chimpanzee (Pan paniscus) supports and African origin for the human T-lymphotropic/simian T-lymphotropic group of viruses. J. Gen. Virol. 77:1996;1089-1099.
85. Vandamme A.-M., Salemi M., Van Brussel M., Liu H.-F., Van Laethem K., Van Ranst M., Michels L., Desmyter J., Goubau P. African origin of Human T-lymphotropic virus type II (HTLV-II) supported by a new subtype HTLV-IId in Zairean Bambuti Efe pygmies. J. Virol. 72:1998;4327-4340.
86. Vandamme A.-M., Salemi M., Desmyter J. The simian origins of the pathogenic human T-cell lymphotropic virus type I. Trends Microbiol. 6:1998;477-483.
87. Watanabe T., Seiki M., Hirayama Y., Yoshida M. Human T-cell leukemia virus type I is a member of the African subtype of simian viruses (STLV). Virology. 148:1986;385-388.
88. Wattel E., Cavrois M., Gessain A., Wain-Hobson S. Clonal expansion of infected cells: a way of life for HTLV-I. J. Acquir. Immune Defic. Syndrome. 13:1996;S92-S99.
89. Wattel E., Vartanian J.-P., Pannetier C., Wain-Hobson S. Clonal Expansion of human T-cell leukemia virus type I-infected cells in asymptomatic and symptomatic carriers without malignancy. J. Virol. 69:1995;2863-2868.
90. Yoshida M., Miyoshi I., Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc. Natl. Acad. Sci. USA. 79:1982;2031-2035.
91. Zella D., Cavicchini A., Salemi M., Casoli C., Lori F., Achilli G., Cattaneo E., Landini V., Bertazzoni U. Molecular characterization of two isolates of human T cell leukaemia virus type II from Italian drug abusers and comparison of genome structure with other isolates. J. Gen. Virol. 74:1993;437-444.
92. Zella D., Mori L., Sala M., Ferrante P., Casoli C., Magnani G., Achilli G., Cattaneo E., Lori F., Bertazzoni U. HTLV-II infection in Italian drug abusers. Lancet. ii:1990;575-576.